Neuropace
NPCE
NPCE
99 hedge funds and large institutions have $405M invested in Neuropace in 2025 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.42% more ownership
Funds ownership: 78.43% → 78.85% (+0.42%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
99
Holding in Top 10
1
Calls
$20K
Puts
–
Top Buyers
| 1 | +$7.65M | |
| 2 | +$2.37M | |
| 3 | +$1.76M | |
| 4 |
JP Morgan Chase
New York
|
+$1.61M |
| 5 |
Jane Street
New York
|
+$1.57M |
Top Sellers
| 1 | -$6.77M | |
| 2 | -$3.41M | |
| 3 | -$3.02M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$2.93M |
| 5 |
O
OrbiMed
New York
|
-$2.78M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RS
101
R Squared
Central,
Hong Kong
| – |
|
|||
102
AllianceBernstein
Nashville,
Tennessee
| – |
|
|||
|
HI
103
Harbour Investments
Madison,
Wisconsin
| – |
|